GDA-201

Gamida doses first subject in Phase I/II cell therapy trial for lymphomas
Clinical Trials Arena
Thu, 08/11/22 - 12:17 pm
Gamida Cell
natural killer cell therapy
GDA-201
diffuse large B-cell lymphoma
follicular B-cell non-Hodgkin lymphoma